220 related articles for article (PubMed ID: 34595405)
41. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Clinical characterization, mutational landscape, and clinical outcome of patients undergoing hematopoietic stem cell transplantation intensive therapy.
Gil-Lianes J; Mozas P; Baumann T; Combalia A; Baliu-Piqué C; García A; Rovira M; López-Guerra M; Villamor N; Colomer D; Rozman M; Esteve J; Estrach T
Actas Dermosifiliogr; 2024 Jun; ():. PubMed ID: 38852841
[TBL] [Abstract][Full Text] [Related]
42. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Garnache-Ottou F; Vidal C; Biichlé S; Renosi F; Poret E; Pagadoy M; Desmarets M; Roggy A; Seilles E; Soret L; Schillinger F; Puyraimond S; Petrella T; Preudhomme C; Roumier C; MacIntyre EA; Harrivel V; Desbrosses Y; Gruson B; Geneviève F; Thepot S; Drebit Y; Leguay T; Gros FX; Lechevalier N; Saussoy P; Salaun V; Cornet E; Benseddik Z; Veyrat-Masson R; Wagner-Ballon O; Salanoubat C; Maynadié M; Guy J; Caillot D; Jacob MC; Cahn JY; Gressin R; Rose J; Quesnel B; Guerin E; Trimoreau F; Feuillard J; Gourin MP; Plesa A; Baseggio L; Arnoux I; Vey N; Blaise D; Lacroix R; Arnoulet C; Benet B; Dorvaux V; Bret C; Drenou B; Debliquis A; Latger-Cannard V; Bonmati C; Bene MC; Peterlin P; Ticchioni M; Rohrlich PS; Arnaud A; Wickenhauser S; Bardet V; Brechignac S; Papoular B; Raggueneau V; Vargaftig J; Letestu R; Lusina D; Braun T; Foissaud V; Tamburini J; Bennani H; Freynet N; Cordonnier C; Le Garff-Tavernier M; Jacques N; Maloum K; Roos-Weil D; Bouscary D; Asnafi V; Lhermitte L; Suarez F; Lengline E; Féger F; Battipaglia G; Mohty M; Bouyer S; Ghoual O; Dindinaud E; Basle C; Puyade M; Lafon C; Fest T; Roussel M; Cahu X; Bera E; Daliphard S; Jardin F; Campos L; Solly F; Guyotat D; Galoisy AC; Eischen A; Mayeur-Rousse C; Guffroy B; Recher C; Loosveld M; Garnier A; Barlogis V; Rosenthal MA; Brun S; Contentin N; Maury S; Callanan M; Lefebvre C; Maillard N; Okamba P; Ferrand C; Adotevi O; Saas P; Angelot-Delettre F; Binda D; Deconinck E
Blood Adv; 2019 Dec; 3(24):4238-4251. PubMed ID: 31869411
[TBL] [Abstract][Full Text] [Related]
43. Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic.
Cernan M; Szotkowski T; Hisemova M; Cetkovsky P; Sramkova L; Stary J; Racil Z; Mayer J; Sramek J; Jindra P; Visek B; Zak P; Novak J; Kozak T; Furst T; Papajik T
Neoplasma; 2020 May; 67(3):650-659. PubMed ID: 32064883
[TBL] [Abstract][Full Text] [Related]
44. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
Lee SS; McCue D; Pemmaraju N
Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559
[TBL] [Abstract][Full Text] [Related]
45. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry.
Pennisi M; Cesana C; Cittone MG; Bandiera L; Scarpati B; Mancini V; Soriani S; Veronese S; Truini M; Rossini S; Cairoli R
Case Rep Hematol; 2017; 2017():4984951. PubMed ID: 28409040
[TBL] [Abstract][Full Text] [Related]
46. Good clinical response in a rare aggressive hematopoietic neoplasm: plasmacytoid dendritic cell leukemia with no cutaneous lesions responding to 4 donor lymphocyte infusions following transplant.
Steinberg A; Kansal R; Wong M; Lopez A; Lim S; Lopategui J; Lill M
Case Rep Transplant; 2011; 2011():651906. PubMed ID: 23198261
[TBL] [Abstract][Full Text] [Related]
47. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy.
Deotare U; Yee KW; Le LW; Porwit A; Tierens A; Musani R; Barth D; Torlakovic E; Schimmer A; Schuh AC; Seftel M; Minden MD; Gupta V; Hyjek E
Am J Hematol; 2016 Mar; 91(3):283-6. PubMed ID: 26619305
[TBL] [Abstract][Full Text] [Related]
48. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.
Dang X; Zhou D; Meng L; Bi L
J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792
[TBL] [Abstract][Full Text] [Related]
49. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
Zhang X; Sun J; Yang M; Wang L; Jin J
Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
[TBL] [Abstract][Full Text] [Related]
50. Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.
Amitay-Laish I; Sundram U; Hoppe RT; Hodak E; Medeiros BC; Kim YH
JAAD Case Rep; 2017 Jul; 3(4):310-315. PubMed ID: 28752118
[No Abstract] [Full Text] [Related]
51. Effective Treatment of a Childhood Blastic Plasmacytoid Dendritic Cell Neoplasm with a Cutaneous Tumor Alone by Stem Cell Transplantation with Reduced Intensity Conditioning.
Shimomura M; Asano T; Furue A; Miki M; Sera Y; Kawaguchi H; Nakamura K; Kobayashi M
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):26-31. PubMed ID: 27408349
[TBL] [Abstract][Full Text] [Related]
52. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
53. Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects.
Trottier AM; Cerquozzi S; Owen CJ
Blood Lymphat Cancer; 2017; 7():85-93. PubMed ID: 31360087
[TBL] [Abstract][Full Text] [Related]
54. Blastic plasmacytoid dendritic cell leukemia successfully treated by autologous hematopoietic stem cell transplantation to a remission of 48-month duration.
Goren Sahin D; Akay OM; Usküdar Teke H; Andıc N; Gunduz E; Gulbas Z
Case Rep Hematol; 2013; 2013():471628. PubMed ID: 24396617
[TBL] [Abstract][Full Text] [Related]
55. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant.
Yun S; Chan O; Kerr D; Vincelette ND; Idrees A; Mo Q; Sweet K; Lancet JE; Kharfan-Dabaja MA; Zhang L; Sokol L
Blood Adv; 2020 Jul; 4(14):3435-3442. PubMed ID: 32722779
[TBL] [Abstract][Full Text] [Related]
56. Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience.
Heinicke T; Hütten H; Kalinski T; Franke I; Bonnekoh B; Fischer T
Ann Hematol; 2015 Feb; 94(2):283-7. PubMed ID: 25138222
[TBL] [Abstract][Full Text] [Related]
57. Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.
Pemmaraju N; Utengen A; Gupta V; Thompson MA; Lane AA
Curr Hematol Malig Rep; 2017 Dec; 12(6):592-597. PubMed ID: 29064025
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
[TBL] [Abstract][Full Text] [Related]
59. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
[TBL] [Abstract][Full Text] [Related]
60. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
